JP2009161522A5 - - Google Patents

Download PDF

Info

Publication number
JP2009161522A5
JP2009161522A5 JP2008313985A JP2008313985A JP2009161522A5 JP 2009161522 A5 JP2009161522 A5 JP 2009161522A5 JP 2008313985 A JP2008313985 A JP 2008313985A JP 2008313985 A JP2008313985 A JP 2008313985A JP 2009161522 A5 JP2009161522 A5 JP 2009161522A5
Authority
JP
Japan
Prior art keywords
extract
kotarahimu
maltotriitol
lactosucrose
pullulan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008313985A
Other languages
Japanese (ja)
Other versions
JP2009161522A (en
JP5442243B2 (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2008313985A priority Critical patent/JP5442243B2/en
Priority claimed from JP2008313985A external-priority patent/JP5442243B2/en
Publication of JP2009161522A publication Critical patent/JP2009161522A/en
Publication of JP2009161522A5 publication Critical patent/JP2009161522A5/ja
Application granted granted Critical
Publication of JP5442243B2 publication Critical patent/JP5442243B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (3)

コタラヒム抽出物を有効成分として含有すると共に、デキストリン、プルラン、環状四糖、ラクトスクロース、トレハロース、マルチトール、マルトトリイトール、マルトテトライトール及び糖転移ビタミンから選ばれる糖質の何れか１種又は２種以上を含有する腎障害抑制剤。It contains a Kotarahim extract as an active ingredient, and any one of carbohydrates selected from dextrin, pullulan, cyclic tetrasaccharide, lactosucrose, trehalose, maltitol, maltotriitol, maltotetritol and glycosylated vitamins or A renal disorder inhibitor containing two or more . 水又はアルコール水溶液で抽出したコタラヒム抽出物と共に、コタラヒム抽出物の固形分１質量部に対して、デキストリン、プルラン、環状四糖、ラクトスクロース、トレハロース、マルチトール、マルトトリイトール、マルトテトライトール及び糖転移ビタミンから選ばれる糖質の何れか１種又は２種以上を、合計で０．０２乃至２００質量部の割合で含有する賢障害抑制剤。 With Kotarahimu extract extracted with water or an aqueous alcohol solution, the solid content, 1 part by mass of Kotarahimu extract, dextrin down, pullulan, cyclic tetrasaccharide, lactosucrose, trehalose, maltitol, maltotriitol, malto Te Tri Torr and any one or two or more kinds, Ken disorder inhibitor you in a proportion of 0.02 to 200 parts by weight in total of the carbohydrate selected glycosyltransferase vitamins or al. 経口摂取用の顆粒、粉末、カプセル又は錠剤の形態である請求項１又は２記載の腎障害抑制剤。The renal failure inhibitor according to claim 1 or 2, which is in the form of granules, powder, capsules or tablets for oral consumption .
JP2008313985A 2007-12-11 2008-12-10 Renal disorder inhibitor Active JP5442243B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008313985A JP5442243B2 (en) 2007-12-11 2008-12-10 Renal disorder inhibitor

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007320085 2007-12-11
JP2007320085 2007-12-11
JP2008313985A JP5442243B2 (en) 2007-12-11 2008-12-10 Renal disorder inhibitor

Publications (3)

Publication Number Publication Date
JP2009161522A JP2009161522A (en) 2009-07-23
JP2009161522A5 true JP2009161522A5 (en) 2012-02-23
JP5442243B2 JP5442243B2 (en) 2014-03-12

Family

ID=40964554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008313985A Active JP5442243B2 (en) 2007-12-11 2008-12-10 Renal disorder inhibitor

Country Status (1)

Country Link
JP (1) JP5442243B2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012095746A2 (en) 2011-01-11 2012-07-19 Capsugel Belgium Nv New hard capsules
JPWO2013133390A1 (en) * 2012-03-08 2015-07-30 タカノ株式会社 Antinephrotic drugs
US20160008392A1 (en) * 2013-03-01 2016-01-14 Hayashibara Co., Ltd. Agent for lifestyle-related disease and oral composition comprising same
CA3059529A1 (en) 2017-04-14 2018-10-18 Capsugel Belgium Nv Process for making pullulan
CN110678170A (en) 2017-04-14 2020-01-10 比利时胶囊公司 Pullulan polysaccharide capsule
JP7408466B2 (en) 2020-04-02 2024-01-05 小林製薬株式会社 Oral composition and method for improving harsh taste
CN111705322B (en) * 2020-06-24 2022-02-22 威海惠安康生物科技有限公司 Stevioside and zinc acetate compound pickling corrosion inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3401708B2 (en) * 1999-11-22 2003-04-28 株式会社京都栄養化学研究所 Salacia food material, method for producing the same, and food containing the food material.
JP2004149471A (en) * 2002-10-31 2004-05-27 Shiratori Pharmaceutical Co Ltd Hypoglycemic agent
JP4979181B2 (en) * 2003-01-31 2012-07-18 株式会社ヤクルト本社 Glycation inhibitors and uses thereof
JP5313436B2 (en) * 2006-03-23 2013-10-09 株式会社ナリス化粧品 Maillard reaction inhibitor, external preparation for skin containing the same, and food and drink

Similar Documents

Publication Publication Date Title
JP2009161522A5 (en)
HRP20191495T1 (en) Stabilized sulforaphane
WO2006011159A3 (en) Stabilized pharmaceutical composition containing rabeprazole sodium with improved bioavailability
CL2013001586A1 (en) Rapid dispersion microgranular composition comprising at least one sugar alcohol, a saccharide, or a mixture thereof, at least one super disintegrant and at least one multifunctional additive; oral disintegration tablet comprising the microgranular composition and at least one active ingredient; and manufacturing methods.
PH12015501309A1 (en) Human milk oligosaccharides to ameliorate symptoms of stress
WO2007093642A3 (en) Microparticulate pharmaceutical forms resistant to immediate release of the active principle in the presence of alcohol
JP2011522896A5 (en)
MX2010004178A (en) Matrix-type pharmaceutical solid preparation.
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
WO2009041651A1 (en) Rapidly disintegrating solid preparation
WO2011084593A3 (en) Abuse-resistant formulations
UA107186C2 (en) SOLID FORMS OF BENDAMUSTINE DOSAGE
JP2012031147A5 (en)
MX355339B (en) Hard candy with reduced sugar.
BR112014005134A2 (en) fast dissolving pharmaceutical composition
JP2009537554A5 (en)
UA103025C2 (en) Solid pharmaceutical formulation with delayed release
JP2011502539A5 (en)
NO20082047L (en) Slow release composition, process for its preparation and use thereof
IL210544A (en) Pharmaceutical compositions comprising pyrazole derivatives, orally bioavailable solid dosage forms comprising them and uses thereof in the preparation of medicaments
MX2013006824A (en) Stock cube.
JP2006342148A5 (en)
JP2011246355A5 (en)
IT1401284B1 (en) NEW PHARMACEUTICAL FORMULATIONS SUITABLE FOR ORAL ADMINISTRATION OF DIHYDRATE ESOMEPRAZOLE MAGNESIUM, IN THE FORM OF MUPS TABLETS (MULTI UNIT PELLETS SYSTEM).
JP2008280345A5 (en)